Elevation Oncology Stock (NASDAQ:ELEV), Quotes and News Summary

Q: What sector and industry does Elevation Oncology (ELEV) operate in?

Elevation Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Elevation Oncology Stock (NASDAQ: ELEV) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	10.000 / 1.014M
Day Range	- - -
52 Wk Range	0.363 - 5.890
Market Cap	$190.141M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	9.62%
Days to Cover	4.88

Recent News

Why Aehr Test Systems Shares Are Trading Lower By 15%; Here Are 20 Stocks Moving Premarket

Shares of Aehr Test Systems (NASDAQ: AEHR) shares fell sharply in pre-market trading after the company lowered its full-year revenue guidance. The company said revenue will likely be impacted by an anticipated delay in the timing of new orders from current and new customers.

Avi Kapoor

What's Going On With Elevation Oncology Stock?

Elevation Oncology, Inc. (NASDAQ: ELEV) shares raced higher Monday. The company announced program updates and upcoming 2024 milestones on Friday.

Erica Kollmann

Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on the stock and raised its price target from $35 to $41.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Feb

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Elevation Oncology (ELEV) stock?

You can purchase shares of Elevation Oncology (NASDAQ: ELEV) through any online brokerage.

View our list of the best stock brokerages.

Who are Elevation Oncology's (ELEV) competitors?

Other companies in Elevation Oncology’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA), Galectin Therapeutics (NASDAQ:GALT), bluebird bio (NASDAQ:BLUE) and Atossa Therapeutics (NASDAQ:ATOS).

What is the target price for Elevation Oncology (ELEV) stock?

The latest price target for Elevation Oncology (NASDAQ: ELEV) was reported by Wedbush on Friday, May 3, 2024. The analyst firm set a price target for 8.00 expecting ELEV to rise to within 12 months (a possible 129.89% upside). 11 analyst firms have reported ratings in the last year.

Current Stock Price for Elevation Oncology (ELEV)?

The stock price for Elevation Oncology (NASDAQ: ELEV) is $3.48 last updated May 7, 2024 at 4:00 PM EDT.

Does Elevation Oncology (ELEV) pay a dividend?

There are no upcoming dividends for Elevation Oncology.

When is Elevation Oncology (NASDAQ:ELEV) reporting earnings?

Elevation Oncology’s Q2 earnings are confirmed for Thursday, August 1, 2024.

Is Elevation Oncology (ELEV) going to split?

There is no upcoming split for Elevation Oncology.

What sector and industry does Elevation Oncology (ELEV) operate in?

Elevation Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-